弥漫性内生性桥脑胶质瘤——当前管理与新生物学见解:是否有希望之光?
弥漫性内生性桥脑胶质瘤(DIPG)是最具挑战性的儿童肿瘤之一。历史上因较少获取肿瘤组织研究且错误假设其生物学与幕上高级别星形细胞瘤相似,诸多研究对疾病自然史影响甚微。近期神经外科技术改进使DIPG安全活检成为可能,结合尸检组织更广泛使用,推动了对该肿瘤生物学的认识。组蛋白3变异中反复出现的体细胞功能获得性突变导致赖氨酸27被甲硫氨酸替换(p.Lys27Met,K27M),见于超过85%的DIPG,首次提示表观基因组和组蛋白在本病发病机制中的作用,并促成更统一的诊断标准。随着对DIPG发病机制分子认识的深入,正在识别和研究合理靶点,以期改善DIPG儿童原本黯淡的预后。
要点
- 超过85%的DIPG存在组蛋白3变异K27M突变,提示表观基因组和组蛋白参与发病。
- 神经外科技术改进使DIPG安全活检成为可能,结合尸检组织推动生物学认识。
- 正在识别和研究合理分子靶点,以期改善DIPG儿童预后。
核心结论
- DIPG曾因较少获取肿瘤组织研究且错误假设其生物学与幕上高级别星形细胞瘤相似,诸多研究对疾病自然史影响甚微。
- 组蛋白3变异K27M突变见于超过85%的DIPG,首次提示表观基因组和组蛋白在发病机制中的作用,并促成更统一的诊断标准。
- 随着分子认识深入,正在识别和研究合理靶点,以期改善DIPG儿童原本黯淡的预后。
研究设计与样本
- 综述,检索范围原文未报告。
主要发现
- 超过85%的DIPG存在组蛋白3变异中反复出现的体细胞功能获得性突变,导致赖氨酸27被甲硫氨酸替换(p.Lys27Met,K27M)。
- 神经外科技术改进使DIPG安全活检成为可能,结合尸检组织更广泛使用,推动了对该肿瘤生物学的认识。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diffuse intrinsic pontine glioma (DIPG) has proven to be one of the most challenging of all pediatric cancers. Owing to a historical reticence to obtain tumor tissue for study, and based on an erroneous assumption that the biology of DIPG would mirror that of supratentorial high-grade astrocytomas, innumerable studies have been undertaken-all of which have had a negligible impact on the natural history of this disease. More recently, improvements in neurosurgical techniques have allowed for the safe upfront biopsy of DIPG, which, together with a wider use of autopsy tissue, has led to an evolving understanding of the biology of this tumor. The discovery of a recurrent somatic gain-of-function mutation leading to lysine 27 to methionine (p.Lys27Met, K27M) substitution in histone 3 variants characterizes more than 85% of DIPG, suggesting for the first time the role of the epigenome and histones in the pathogenesis of this disease, and more unified diagnostic criteria. Along with further molecular insights into the pathogenesis of DIPG, rational targets are being identified and studied in the hopes of improving the otherwise dismal outcome for children with DIPG.
引用
- Cohen KJ, Jabado N, Grill J, et al. Diffuse intrinsic pontine gliomas-current management and new biologic insights. Is there a glimmer of hope? Neuro Oncol. 2017. PMID: 28371920. doi:10.1093/neuonc/nox021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。